Synthesis and structure of 1,3-bis(hydroxysilyl)-2,4-dimethyl-2,4-diphenylcyclodisilazane
摘要:
Trans-silylation reactions of (Me3Si)(2)NH with PhRSiCl2 (R = Me, Ph) gave HN(SiMePhCl)(2) (1) or ClMePh-SiNHSiPh2Cl (2). The treatment of 1,3-dichlorodisilazane (1 or 2) with an equimolar amount of n-BuLi led to the formation of 1,3-bis(chloro-silyl)-2,4-dimethyl-2,4-diphenylcyclodisilazane (ClSiMePh)(2)(NSiMePh)(2) (3) or (ClSiPh2)(2)(NSiMePh)(2) (4), which was allowed to hydrolyze to form 1,3-bis(hydroxysilyl)-2,4-dimethyl-2,4-diphenylcyclodisilazane (HOSiMePh)(2)(NSiMePh)(2) (5) or (HOSiPh2)(2)(NSiMePh)(2) (6), respectively. The cyclodisilazane monomers were characterized by elemental analysis, NMR and IR spectroscopy. Compound 3 was obtained as a 4:6 cis/trans mixture while 4 adopted trans-structure considering the hindrance of pendent groups. In addition, the molecular structures of trans-5 and trans-6 were determined by X-ray crystallographic analysis and discussed in detail. (C) 2011 Elsevier B.V. All rights reserved.
Synthesis and structure of 1,3-bis(hydroxysilyl)-2,4-dimethyl-2,4-diphenylcyclodisilazane
摘要:
Trans-silylation reactions of (Me3Si)(2)NH with PhRSiCl2 (R = Me, Ph) gave HN(SiMePhCl)(2) (1) or ClMePh-SiNHSiPh2Cl (2). The treatment of 1,3-dichlorodisilazane (1 or 2) with an equimolar amount of n-BuLi led to the formation of 1,3-bis(chloro-silyl)-2,4-dimethyl-2,4-diphenylcyclodisilazane (ClSiMePh)(2)(NSiMePh)(2) (3) or (ClSiPh2)(2)(NSiMePh)(2) (4), which was allowed to hydrolyze to form 1,3-bis(hydroxysilyl)-2,4-dimethyl-2,4-diphenylcyclodisilazane (HOSiMePh)(2)(NSiMePh)(2) (5) or (HOSiPh2)(2)(NSiMePh)(2) (6), respectively. The cyclodisilazane monomers were characterized by elemental analysis, NMR and IR spectroscopy. Compound 3 was obtained as a 4:6 cis/trans mixture while 4 adopted trans-structure considering the hindrance of pendent groups. In addition, the molecular structures of trans-5 and trans-6 were determined by X-ray crystallographic analysis and discussed in detail. (C) 2011 Elsevier B.V. All rights reserved.